Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aethlon Medical, Inc. - Common Stock (NQ:AEMD)

0.3813 +0.0060 (+1.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 124,153
Open 0.3700
Bid (Size) 0.3600 (1)
Ask (Size) 0.4000 (5)
Prev. Close 0.3753
Today's Range 0.3600 - 0.3999
52wk Range 0.2375 - 1.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga

Performance

YTD
-52.3%
-52.3%
1 Month
-4.9%
-4.9%
3 Month
-39.6%
-39.6%
6 Month
+0.4%
+0.4%
1 Year
-72.0%
-72.0%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
An Overview of Aethlon Medical's Earnings
Via Benzinga
(AEMD) - Analyzing Aethlon Medical's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
US Stocks Higher, Micron Reports Downbeat Sales
Via Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Via Newsfile
Innovation Driving Cancer's Solid Tumors Market
Via Newsfile
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th
From Virtual Investor Conferences
Via GlobeNewswire
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AEMD Stock Earnings: Aethlon Medical Misses EPS for Q1 2025
Via InvestorPlace
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
Via Newsfile
Exposures Product Safety
AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024
Via InvestorPlace
What's Next in Treatments for Cancer Patients with Solid Tumors?
Via Newsfile
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Aethlon Medical, Inc. - Common Stock publicly traded?
Yes, Aethlon Medical, Inc. - Common Stock is publicly traded.
What exchange does Aethlon Medical, Inc. - Common Stock trade on?
Aethlon Medical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aethlon Medical, Inc. - Common Stock?
The ticker symbol for Aethlon Medical, Inc. - Common Stock is AEMD on the Nasdaq Stock Market
What is the current price of Aethlon Medical, Inc. - Common Stock?
The current price of Aethlon Medical, Inc. - Common Stock is 0.3813
When was Aethlon Medical, Inc. - Common Stock last traded?
The last trade of Aethlon Medical, Inc. - Common Stock was at 04/25/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.